Concepedia

Dawn R. Christianson

DR

10

Publications

709

Citations

10

H-Index

2006

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Arrowhead Pharmaceuticals (United States)

Beth Israel Deaconess Medical Center

University of California San Diego

Saint Louis University

Dawn R. Christianson is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

2006–2022

10

Publications

10

Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents

Glauco R. Souza, Dawn R. Christianson, Fernanda I. Staquicini et al. · Proceedings of the National Academy of Sciences · 2006 · 261 citations · Full text

A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys

Kirstin F. Barnhart, Dawn R. Christianson, Patrick W. Hanley et al. · Science Translational Medicine · 2011 · 99 citations · Full text

A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis

Lung‐Yi Mak, Ed Gane, Christian Schwabe et al. · Journal of Hepatology · 2022 · 69 citations

, , +10

Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients

Alice Turner, Jan Stolk, Robert Bals et al. · Journal of Hepatology · 2018 · 65 citations · Full text

, , +13

Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease

Christine I. Wooddell, Keith Blomenkamp, Ryan M. Peterson et al. · JCI Insight · 2020 · 55 citations · Full text

, , +15

Rows per page

1–5 of 10